Contact Dermatitis 2015-02-11

Erythema-multiforme-like, urticarial papular and plaque eruptions from bufexamac: report of 4 cases.

Caroline C D Thai, Lalehvash Moghaddam, William O S Doherty

Index: Contact Dermatitis 31(2) , 97-101, (1994)

Full Text: HTML

Abstract

4 patients developed an erythema-multiforme-like reaction following acute contact dermatitis from 2 different bufexamac-containing topical preparations. Histologically, the lesions did not show changes that were typical of erythema multiforme. Patch testing gave positive reactions to bufexamac at 1, 2, 3 and 4 days. The histological picture of 2 positive test reactions was suggestive of a drug reaction in the 1st, and of an acute eczematous reaction in the 2nd, case. A systemic allergic reaction with spread of lesions could have been involved, following percutaneous absorption of the allergen.


Related Compounds

Related Articles:

[A severe epicutaneous test reaction to the bufexamac in a hemorrhoidal therapeutic preparation].

1999-10-08

[Dtsch. Med. Wochenschr. 124(40) , 1168-70, (1999)]

[A common and insidious side-effect: allergic contact dermatitis caused by bufexamac used in the treatment of dermatitis. Results from the Information Network of Departments of Dermatology (IDVK)].

2005-12-16

[Dtsch. Med. Wochenschr. 130(50) , 2881-6, (2005)]

In vitro photobiochemical characterization of sulfobutylether-β-cyclodextrin formulation of bufexamac.

2011-06-01

[J. Pharm. Biomed. Anal. 55(3) , 591-6, (2011)]

Examinations of the antioxidative properties of the topically administered drug bufexamac reveal new insights into its mechanism of action.

2003-10-01

[J. Pharm. Pharmacol. 55(10) , 1379-88, (2003)]

Allergic contact dermatitis to topical preparations of bufexamac.

2012-08-01

[Australas. J. Dermatol. 53(3) , 207-10, (2012)]

More Articles...